The Minimal Clinically Important Difference for Achievement of Substantial Reperfusion With Endovascular Thrombectomy Devices in Acute Ischemic Stroke Treatment

Conclusions: Neuro-interventionl and noninterventional stroke experts judged that the minimal clinically important difference in comparing thrombectomy devices for achieving substantial reperfusion is 3.1–5%. This MCID, lower than noninferiority margins used in several recent clinical trials, can inform trial designs and clinical development.
Source: Frontiers in Neurology - Category: Neurology Source Type: research